The associations between caffeine treatment and common preterm morbidities: a retrospective cohort analysis
Open Access
- 10 July 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1178976
Abstract
Introduction: Caffeine is one of the most used drugs in the neonatal intensive care units (NICUs). It is widely regarded as beneficial in preventing many morbidities by reducing apnea of prematurity and improving respiratory functions.Methods: Premature infants with gestational ages >25 and n = 355), and the patients not receiving caffeine were classified as Group 2 (n = 120). Despite the higher incidence of respiratory distress syndrome requiring surfactant therapy and a longer duration of respiratory support in Group 2, the rates of bronchopulmonary dysplasia (BPD) and most other common morbidities were quite comparable. The frequency of apnea was statistically lower in the group that received caffeine prophylaxis (p < 0.01).Conclusion: In this retrospective cohort analysis, we found that caffeine prophylaxis significantly decreased apnea attacks however does not prevent respiratory morbidity such as BPD.Keywords
This publication has 28 references indexed in Scilit:
- Prophylactic methylxanthines for endotracheal extubation in preterm infantsCochrane Database of Systematic Reviews, 2010
- The Effects of Caffeine on the Preterm Sheep Ductus ArteriosusPediatric Research, 2007
- Caffeine Therapy for Apnea of PrematurityNew England Journal of Medicine, 2006
- Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary DysplasiaPediatrics, 2005
- Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: A pilot studyActa Paediatrica, 2005
- Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: A pilot studyActa Paediatrica, 2005
- Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasiaPediatric Pulmonology, 1989
- [46] Methylxanthine inhibitors of phosphodiesterases1988
- Neonatal necrotizing enterocolitis: Pathogenesis, classification, and spectrum of illnessCurrent Problems in Pediatrics, 1987
- CHLOROQUINE, QUININE, PROCAINE, QUINIDINE, TRICYCLIC ANTIDEPRESSANTS, AND METHYLXANTHINES AS PROSTAGLANDIN AGONISTS AND ANTAGONISTSThe Lancet, 1976